What Does the Market Think About Ascendis Pharma AS?
I'm PortAI, I can summarize articles.
Ascendis Pharma AS's ( NYSE: ASND ) short interest as a percent of float has fallen 14.63% since its last report. According to exchange reported data, there are now 2.29 million shares sold short, which is 4.55% of all regular shares that are available for trading.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments